Tremfya Market is segmented by Product (Biologic Monotherapy, Combination Therapy, Auto Injector Formulation, Hospital Grade Formulation), Indication (Plaque Psoriasis, Psoriatic Arthritis, Inflammatory Skin Disorders), Mechanism of Action (Interleukin 23 Inhibition, Immune Modulation), and Region, with forecasts covering the period from 2026 to 2036.